Vaccinex, Inc. (VCNX) Financials
VCNX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 2.6 million | 6.4 million |
| 2023-06-30 | 3.1 million | 3.5 million |
| 2023-03-31 | 4.9 million | 2.5 million |
| 2022-12-31 | 8.0 million | 2.8 million |
VCNX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -3.1 million | 115000 |
| 2023-06-30 | -5.5 million | 126000 |
| 2023-03-31 | -5.1 million | 129000 |
| 2022-12-31 | -4.6 million | 132000 |
VCNX Net Income
No data available :(
VCNX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 127000 | - | 188000 |
| 2023-06-30 | 1.9 million | - | 229000 |
| 2023-03-31 | 3.3 million | - | 270000 |
| 2022-12-31 | 6.4 million | - | 310000 |
VCNX Shares Outstanding
VCNX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 18000 | 4.4 million | 1.5 million | - |
| 2023-06-30 | - | 5.1 million | 2.0 million | - |
| 2023-03-31 | 49000 | 3.8 million | 1.7 million | - |
| 2022-12-31 | 50000 | 3.7 million | 1.6 million | - |
VCNX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 20000 | 31000 |
| 2023-06-30 | - | 30000 |
| 2023-03-31 | 550000 | 31000 |
| 2022-12-31 | 50000 | 45000 |
VCNX
Price: $6.05
52 week price:
Earnings Per Share: -83.86 USD
P/E Ratio: -0.10
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 494085
Market Capitalization: 7.9 million